Lung cancer patients’ CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells

Podobne knjige/članki

• The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4(+) T lymphocytes
  od: Thompson, James A., et al.
  Izdano: (2007)
• MHC II Lung Cancer Vaccines Prime and Boost Tumor-specific CD4(+) T Cells that Cross-React with Multiple Histologic Subtypes of Non-small Cell Lung Cancer Cells
  od: Srivastava, Minu K., et al.
  Izdano: (2010)
• Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8(+) cytotoxic, tumor-specific T cells
  od: Bosch, Jacobus J., et al.
  Izdano: (2009)
• Myeloid-derived Suppressor Cells Inhibit T Cell Activation by Depleting Cystine and Cysteine
  od: Srivastava, Minu K., et al.
  Izdano: (2009)
• Myeloid Derived-Suppressor Cells: Their role in cancer and obesity
  od: Ostrand-Rosenberg, Suzanne
  Izdano: (2018)